Orthopediatrics Total Liab vs Capital Surpluse Analysis

KIDS Stock

USD 29.23 1.03 3.40%

Orthopediatrics Corp financial indicator trend analysis is much more than just breaking down Orthopediatrics Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orthopediatrics Corp is a good investment. Please check the relationship between Orthopediatrics Corp Total Liab and its Capital Surpluse accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orthopediatrics Corp Total Liab account and Capital Surpluse. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Orthopediatrics Corp's Total Liab and Capital Surpluse is 0.8. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Orthopediatrics Corp, assuming nothing else is changed. The correlation between historical values of Orthopediatrics Corp's Total Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Orthopediatrics Corp are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Liab i.e., Orthopediatrics Corp's Total Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.8

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Capital Surpluse

Most indicators from Orthopediatrics Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orthopediatrics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Discontinued Operations is likely to drop (988.5 K) in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	2.4M	198K	188.1K
Depreciation And Amortization	11.8M	11.3M	17.4M	18.3M

Interest Expense Depreciation And Amortization

Orthopediatrics Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.09	0.85	0.98	1.0	0.71	0.96	0.93	0.6	-0.4	-0.98	0.9	0.26	0.99	-0.54	0.85	0.98	0.89	0.91	0.61	0.97	0.88	1.0	0.82	0.96	0.95
Short Long Term Debt Total	-0.09		0.21	-0.1	-0.09	-0.54	0.13	-0.18	-0.51	-0.26	0.04	-0.14	0.59	-0.18	0.82	-0.12	0.1	-0.13	-0.27	-0.16	0.05	-0.36	-0.07	-0.23	0.0	-0.06
Other Current Liab	0.85	0.21		0.8	0.88	0.32	0.86	0.71	0.14	-0.11	-0.78	0.65	0.13	0.83	-0.33	0.59	0.91	0.63	0.66	0.17	0.93	0.52	0.84	0.44	0.93	0.74
Total Current Liabilities	0.98	-0.1	0.8		0.96	0.79	0.91	0.9	0.69	-0.35	-0.97	0.9	0.22	0.98	-0.56	0.78	0.95	0.85	0.87	0.68	0.95	0.86	0.96	0.87	0.93	0.93
Total Stockholder Equity	1.0	-0.09	0.88	0.96		0.67	0.96	0.92	0.55	-0.37	-0.96	0.89	0.24	0.98	-0.53	0.85	0.98	0.88	0.9	0.55	0.98	0.85	0.99	0.78	0.97	0.94
Other Liab	0.71	-0.54	0.32	0.79	0.67		0.53	0.69	0.96	-0.23	-0.74	0.71	-0.03	0.77	-0.77	0.55	0.6	0.66	0.73	0.83	0.62	0.84	0.69	0.88	0.61	0.68
Net Tangible Assets	0.96	0.13	0.86	0.91	0.96	0.53		0.87	0.44	-0.55	-0.95	0.87	0.48	0.91	-0.3	0.88	0.97	0.88	0.84	0.54	0.94	0.79	0.97	0.73	0.92	0.93
Property Plant And Equipment Net	0.93	-0.18	0.71	0.9	0.92	0.69	0.87		0.62	-0.42	-0.91	0.96	0.27	0.92	-0.53	0.88	0.88	0.97	0.97	0.65	0.86	0.94	0.93	0.88	0.86	0.97
Current Deferred Revenue	0.6	-0.51	0.14	0.69	0.55	0.96	0.44	0.62		-0.38	-0.66	0.68	0.11	0.65	-0.64	0.55	0.48	0.63	0.66	0.89	0.47	0.8	0.58	0.88	0.44	0.62
Net Debt	-0.4	-0.26	-0.11	-0.35	-0.37	-0.23	-0.55	-0.42	-0.38		0.49	-0.49	-0.93	-0.29	-0.25	-0.69	-0.4	-0.6	-0.45	-0.61	-0.28	-0.49	-0.44	-0.53	-0.21	-0.51
Retained Earnings	-0.98	0.04	-0.78	-0.97	-0.96	-0.74	-0.95	-0.91	-0.66	0.49		-0.93	-0.36	-0.96	0.46	-0.85	-0.96	-0.91	-0.9	-0.71	-0.94	-0.89	-0.98	-0.87	-0.93	-0.97
Accounts Payable	0.9	-0.14	0.65	0.9	0.89	0.71	0.87	0.96	0.68	-0.49	-0.93		0.34	0.89	-0.45	0.9	0.85	0.95	0.91	0.72	0.82	0.92	0.9	0.91	0.81	0.98
Cash	0.26	0.59	0.13	0.22	0.24	-0.03	0.48	0.27	0.11	-0.93	-0.36	0.34		0.14	0.54	0.52	0.34	0.44	0.26	0.43	0.22	0.26	0.31	0.34	0.14	0.38
Non Current Assets Total	0.99	-0.18	0.83	0.98	0.98	0.77	0.91	0.92	0.65	-0.29	-0.96	0.89	0.14		-0.63	0.79	0.96	0.85	0.9	0.63	0.96	0.88	0.98	0.83	0.96	0.92
Long Term Debt	-0.54	0.82	-0.33	-0.56	-0.53	-0.77	-0.3	-0.53	-0.64	-0.25	0.46	-0.45	0.54	-0.63		-0.34	-0.39	-0.43	-0.59	-0.31	-0.47	-0.6	-0.51	-0.5	-0.5	-0.42
Cash And Short Term Investments	0.85	-0.12	0.59	0.78	0.85	0.55	0.88	0.88	0.55	-0.69	-0.85	0.9	0.52	0.79	-0.34		0.79	0.94	0.87	0.6	0.74	0.86	0.87	0.78	0.71	0.91
Net Receivables	0.98	0.1	0.91	0.95	0.98	0.6	0.97	0.88	0.48	-0.4	-0.96	0.85	0.34	0.96	-0.39	0.79		0.84	0.86	0.56	0.99	0.79	0.98	0.76	0.97	0.92
Common Stock Total Equity	0.89	-0.13	0.63	0.85	0.88	0.66	0.88	0.97	0.63	-0.6	-0.91	0.95	0.44	0.85	-0.43	0.94	0.84		0.96	0.67	0.8	0.93	0.91	0.87	0.79	0.97
Common Stock Shares Outstanding	0.91	-0.27	0.66	0.87	0.9	0.73	0.84	0.97	0.66	-0.45	-0.9	0.91	0.26	0.9	-0.59	0.87	0.86	0.96		0.66	0.83	0.95	0.92	0.87	0.83	0.94
Non Current Liabilities Total	0.61	-0.16	0.17	0.68	0.55	0.83	0.54	0.65	0.89	-0.61	-0.71	0.72	0.43	0.63	-0.31	0.6	0.56	0.67	0.66		0.5	0.81	0.61	0.92	0.46	0.68
Inventory	0.97	0.05	0.93	0.95	0.98	0.62	0.94	0.86	0.47	-0.28	-0.94	0.82	0.22	0.96	-0.47	0.74	0.99	0.8	0.83	0.5		0.77	0.96	0.72	0.99	0.89
Other Current Assets	0.88	-0.36	0.52	0.86	0.85	0.84	0.79	0.94	0.8	-0.49	-0.89	0.92	0.26	0.88	-0.6	0.86	0.79	0.93	0.95	0.81	0.77		0.88	0.94	0.77	0.91
Other Stockholder Equity	1.0	-0.07	0.84	0.96	0.99	0.69	0.97	0.93	0.58	-0.44	-0.98	0.9	0.31	0.98	-0.51	0.87	0.98	0.91	0.92	0.61	0.96	0.88		0.81	0.95	0.95
Total Liab	0.82	-0.23	0.44	0.87	0.78	0.88	0.73	0.88	0.88	-0.53	-0.87	0.91	0.34	0.83	-0.5	0.78	0.76	0.87	0.87	0.92	0.72	0.94	0.81		0.69	0.88
Property Plant And Equipment Gross	0.96	0.0	0.93	0.93	0.97	0.61	0.92	0.86	0.44	-0.21	-0.93	0.81	0.14	0.96	-0.5	0.71	0.97	0.79	0.83	0.46	0.99	0.77	0.95	0.69		0.89
Short Long Term Debt	0.95	-0.06	0.74	0.93	0.94	0.68	0.93	0.97	0.62	-0.51	-0.97	0.98	0.38	0.92	-0.42	0.91	0.92	0.97	0.94	0.68	0.89	0.91	0.95	0.88	0.89

Click cells to compare fundamentals

Orthopediatrics Corp Account Relationship Matchups

Orthopediatrics Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	194.6M	320.4M	304.3M	427.7M	449.6M	472.1M
Short Long Term Debt Total	26.3M	1.5M	1.0M	907K	23.8M	24.9M
Other Current Liab	2.7M	1.7M	2.0M	13.6M	18.7M	19.7M
Total Current Liabilities	13.7M	35.0M	29.7M	30.9M	41.7M	43.7M
Total Stockholder Equity	142.4M	234.8M	225.4M	378.6M	377.0M	395.9M
Net Tangible Assets	109.6M	100.0M	83.3M	211.9M	243.7M	255.9M
Property Plant And Equipment Net	21.3M	27.2M	28.5M	34.3M	41.0M	21.9M
Current Deferred Revenue	4.3M	23.1M	18.2M	6.0M	6.8M	7.8M
Net Debt	(44.5M)	(27.3M)	(6.6M)	(8.1M)	(9.3M)	(9.7M)
Retained Earnings	(128.8M)	(161.8M)	(178.0M)	(176.8M)	(197.7M)	(207.6M)
Accounts Payable	6.5M	10.0M	9.3M	11.2M	12.6M	7.2M
Cash	70.8M	28.8M	7.6M	9.0M	33.0M	29.1M
Non Current Assets Total	66.5M	162.0M	170.6M	201.0M	223.1M	234.2M
Long Term Debt	26.1M	1.0M	907K	763K	9.9M	10.3M
Cash And Short Term Investments	70.8M	83.9M	53.5M	118.3M	82.3M	57.7M
Net Receivables	16.6M	17.5M	17.9M	24.8M	34.6M	36.3M
Common Stock Shares Outstanding	14.6M	18.1M	19.3M	20.9M	22.7M	14.9M
Liabilities And Stockholders Equity	194.6M	320.4M	304.3M	427.7M	449.6M	472.1M
Non Current Liabilities Total	38.5M	50.6M	49.2M	18.2M	30.9M	30.7M
Inventory	38M	53.0M	57.6M	78.2M	105.9M	111.1M
Other Current Assets	2.7M	4.0M	4.6M	4.0M	3.8M	2.4M
Other Stockholder Equity	271.2M	388.6M	394.9M	560.8M	580.3M	609.3M
Total Liab	52.2M	85.6M	78.9M	49.1M	72.6M	51.2M
Property Plant And Equipment Gross	21.3M	27.2M	51.6M	65.1M	80.6M	84.7M
Short Long Term Debt	124K	131K	137K	144K	152K	134.6K
Total Current Assets	128.1M	158.4M	133.6M	226.7M	226.5M	122.2M
Accumulated Other Comprehensive Income	(3K)	7.9M	8.5M	(5.4M)	(5.5M)	(5.2M)
Short Term Debt	124K	131K	137K	144K	10.3M	10.8M
Intangible Assets	19.0M	64.2M	69.8M	79.9M	84.6M	88.8M
Property Plant Equipment	21.3M	27.2M	28.5M	34.3M	39.4M	41.4M
Other Assets	1.6M	1.9M	2.2M	14.0K	12.6K	11.9K
Capital Surpluse	271.2M	388.6M	394.9M	560.8M	644.9M	677.2M
Non Currrent Assets Other	(54.1M)	8.2M	9.5M	(6.0M)	1.1M	1.1M
Retained Earnings Total Equity	(128.8M)	(161.8M)	(178.0M)	(176.8M)	(159.1M)	(167.0M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Orthopediatrics Corp is a strong investment it is important to analyze Orthopediatrics Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orthopediatrics Corp's future performance. For an informed investment choice regarding Orthopediatrics Stock, refer to the following important reports:

How To Invest In Orthopediatrics

Details

Is Orthopediatrics Stock a good investment?

Details

What is Orthopediatrics Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Orthopediatrics Stock analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.

	Commodity Directory Find actively traded commodities issued by global exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

6.559

Quarterly Revenue Growth

0.214

Return On Assets

(0.04)

Return On Equity

(0.06)

The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Orthopediatrics Total Liab vs Capital Surpluse Analysis

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Total Liab

Capital Surpluse

Orthopediatrics Corp fundamental ratios Correlations

Orthopediatrics Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Orthopediatrics Corp fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Orthopediatrics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Net Receivables
Property Plant And Equipment Gross	+ 0.99	Inventory

Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Total Assets
Short Long Term Debt	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Total Current Liabilities
Net Receivables	- 0.96	Retained Earnings
Non Current Assets Total	- 0.96	Retained Earnings